Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer

MLA

Mishra, Alok K., et al. “Targeting the GPI Transamidase Subunit GPAA1 Abrogates the CD24 Immune Checkpoint in Ovarian Cancer.” Cell Reports, vol. 43, no. 4, Apr. 2024. EBSCOhost, https://doi.org/10.1016/j.celrep.2024.114041.

APA

Mishra, A. K., Ye, T., Banday, S., Thakare, R. P., Su, C. T.-T., Pham, N. N. H., Ali, A., Kulshreshtha, A., Chowdhury, S. R., Simone, T. M., Hu, K., Zhu, L. J., Eisenhaber, B., Deibler, S. K., Simin, K., Thompson, P. R., Kelliher, M. A., Eisenhaber, F., Malonia, S. K., & Green, M. R. (2024). Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer. Cell Reports, 43(4). https://doi.org/10.1016/j.celrep.2024.114041

Chicago

Mishra, Alok K., Tianyi Ye, Shahid Banday, Ritesh P. Thakare, Chinh Tran-To Su, Ngoc N.H. Pham, Amjad Ali, et al. 2024. “Targeting the GPI Transamidase Subunit GPAA1 Abrogates the CD24 Immune Checkpoint in Ovarian Cancer.” Cell Reports 43 (4). doi:10.1016/j.celrep.2024.114041.